Transcranial Magnetic Stimulation for Dystonia

This trial explores how repetitive transcranial magnetic stimulation (rTMS) affects brain activity in individuals with dystonia, a condition causing involuntary muscle movements. The researchers aim to assess changes in brain connectivity using brain scans. This trial suits those with dystonia affecting the head, neck, trunk, or limbs, who have not experienced certain medical conditions like stroke or Parkinson’s. As an Early Phase 1 trial, this research focuses on understanding how rTMS works in people, offering a unique opportunity to be among the first to explore its effects.

The trial does not specify if you need to stop taking your current medications, but it does mention that long-term use of benzodiazepines, neuroleptics, or anticonvulsants is not allowed. Also, you cannot have had botulinum toxin within 12 weeks before the trial starts.

Research has shown that repetitive transcranial magnetic stimulation (rTMS) is generally safe and well-tolerated. One study found the treatment safe for most patients, with no major health changes over time. Another study highlighted that rTMS can stimulate the brain without harm and does not require surgery. Although the FDA has not yet approved rTMS for treating dystonia specifically, it has been researched for other conditions and has shown promise without serious side effects. Overall, past research suggests that rTMS is a safe option for many people.¹²³⁴⁵

Most treatments for dystonia, such as botulinum toxin injections and oral medications, focus on managing symptoms by relaxing muscles or altering brain chemicals. However, repetitive Transcranial Magnetic Stimulation (rTMS) offers a unique approach by non-invasively targeting and modulating brain networks involved in movement control. Researchers are excited because rTMS could potentially rewire brain pathways and offer lasting relief without the side effects typically associated with conventional medications. This innovative method provides a new hope for improving quality of life in dystonia patients by addressing the root cause rather than just alleviating symptoms.

Studies have shown that repetitive transcranial magnetic stimulation (rTMS) might help treat dystonia, a movement disorder. One study demonstrated significant improvement in patients with secondary dystonia after receiving low-frequency rTMS on the premotor cortex. Another study found that 10 sessions of active rTMS were more effective than a single session in improving symptoms. Although the FDA has not yet approved rTMS for dystonia, some research suggests it can reduce muscle spasms and pain in patients with secondary generalized dystonia. However, results can vary, and more research is needed to fully understand its potential. Participants in this trial will receive active rTMS to investigate its effects on brain networks in patients with dystonia.¹²⁶⁷⁸